Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3546 |
|
| Actual shortage: | 240 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3292 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PERINDOPRIL-INDAPAMIDE | 2.5MG 8MG | TABLET | Actual shortage | 2025-10-10 | 2025-10-10 | 269347 |
| APO-PERINDOPRIL-INDAPAMIDE | 2.5MG 8MG | TABLET | Actual shortage | 2025-10-10 | 2025-10-10 | 269350 |
| APO-PERINDOPRIL/AMLODIPINE | 7MG 5MG | TABLET | Resolved | 2020-04-22 | 2020-04-28 | 112741 |
| APO-PERINDOPRIL/AMLODIPINE | 14MG 10MG | TABLET | Resolved | 2020-08-19 | 2020-09-25 | 122486 |
| APO-PERINDOPRIL/AMLODIPINE | 7MG 5MG | TABLET | Resolved | 2020-08-19 | 2020-09-25 | 122489 |
| APO-PERINDOPRIL/AMLODIPINE | 14MG 10MG | TABLET | Resolved | 2020-10-07 | 2020-12-30 | 125818 |
| APO-PERINDOPRIL/AMLODIPINE | 7MG 5MG | TABLET | Resolved | 2020-12-18 | 2020-12-30 | 130413 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2021-10-08 | 2021-10-25 | 146910 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2023-06-02 | 2023-06-29 | 193617 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2023-09-15 | 2023-09-28 | 204424 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2023-10-20 | 2023-10-27 | 207704 |
| APO-PERINDOPRIL/AMLODIPINE | 5MG 7MG | TABLET | Resolved | 2023-10-20 | 2023-10-27 | 207707 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2023-11-10 | 2024-02-09 | 209936 |
| APO-PERINDOPRIL/AMLODIPINE | 5MG 7MG | TABLET | Resolved | 2023-11-24 | 2023-12-15 | 211490 |
| APO-PERINDOPRIL/AMLODIPINE | 2.5MG 3.5MG | TABLET | Resolved | 2023-12-01 | 2023-12-15 | 212386 |
| APO-PERINDOPRIL/AMLODIPINE | 10MG 14MG | TABLET | Resolved | 2024-04-05 | 2024-04-19 | 224586 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Resolved | 2020-06-18 | 2022-02-10 | 118310 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Resolved | 2021-01-22 | 2022-02-10 | 132363 |
| APO-PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-23 | 2021-05-03 | 137965 |
| APO-PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-09-03 | 2021-09-20 | 145178 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |